1. Home
  2. News
  3. Clarity Pharmaceuticals Ltd.
  4. Update on China Grand Pharmaceutical and Healthcare Holdings
More Clarity Pharmaceuticals Ltd. news
Clarity Pharmaceuticals Ltd.ASX: CU6

Update on China Grand Pharmaceutical and Healthcare Holdings

Feb 27, 2022 at 11:14 PM EST · Issued by Clarity Pharmaceuticals Ltd.

Filed with ASX · Feb 27, 2022 at 11:14 PM EST · 2 pages · English

On 6ix: 6ix.com/news/update-on-china-grand-pharmaceutical-and-healthcare-holdings

Clarity Pharmaceuticals Ltd. on 6ix

In the deck

  • Clarity Pharmaceuticals — Investor Presentation (March 2022)28 slidesMar 3, 2022

Earlier from Clarity Pharmaceuticals

  • First patient treated in cohort 2 neuroblastoma trialFeb 24, 2022
  • US FDA Study May Proceed letter for Cu-64 SAR-bisPSMAFeb 6, 2022
  • Clarity receives $3.26 million R&D tax incentive refundFeb 3, 2022
  • SARTATE Neuroblastoma trial advances to cohort 2Jan 31, 2022
  • Managing Directors Presentation to Annual General MeetingNov 24, 2021

Later from Clarity Pharmaceuticals

  • Half Year AccountsFeb 28, 2022
  • Clarity Half Yearly ReportFeb 28, 2022
  • First patient treated in the prostate cancer imaging trialApr 21, 2022
  • Presentation Jefferies Biotech SummitMay 27, 2022
  • Notification regarding unquoted securities - CU6Jun 1, 2022
All Clarity Pharmaceuticals news releases↗

Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.

Follow Clarity Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer